Who are Dogwood Therapeutics, Inc.'s main suppliers?

Dogwood Therapeutics, Inc. (DWTX) key suppliers include: UNIVERSITY-OF-ALABAMA, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/DWTX.

Who are Dogwood Therapeutics, Inc.'s major customers?

Dogwood Therapeutics, Inc. (DWTX) key customers include: PRIDCOR-THERAPEUTICS-LLC, ORANY, ORANY. View the full customer network at chainsifter.com/chain/DWTX.

What sector is Dogwood Therapeutics, Inc. in?

Dogwood Therapeutics, Inc. (DWTX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

DWTX Supply Chain: Dogwood Therapeutics, Inc. Supplier List & 8 Relationships

3Suppliers

3Customers

2Debt Items

20Related Chains

Dogwood Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
UNIVERSITY-OF-ALABAMA	UNIVERSITY-OF-ALABAMA	90%	In consideration for the License Agreement, the University of Alabama received membership interests in the Company representing 10% of the issued membership interests at that time.
ORANY	ORANY	72%	ct which will be distributed to the clinical sites for reconstitution and use in clinical trials. We are presently developing a synthetically formulated version of Halneuron ® to be used for both Pha…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: ct which will be distributed to the clinical sites for reconstitution and use in clinical trials. We are presently d…

Dogwood Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
PRIDCOR-THERAPEUTICS-LLC	PRIDCOR-THERAPEUTICS-LLC	92%	In exchange, the Company is entitled to a tiered royalty on net sales of up to 15 % upon commercialization of IMC-1 or IMC-2.
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from ORAN…
ORANY	ORANY	72%	s or the imposition of civil or criminal penalties. The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs or devices may be promot…

Dogwood Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DWTX-DEBT-9187	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
DWTX-DEBT-9186	Warrants outstanding: 20000	90%	xbrl warrant detail from xbrl 2022-09-30.

Dogwood Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Dogwood Therapeutics, Inc..

Dogwood Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
DWTX-OWNER-ARMISTICE-CAPITAL-LLC	ARMISTICE CAPITAL, LLC	90%	13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 15 tracked holders.

Dogwood Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
AZN	AstraZeneca PLC	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AXSM	Axsome Therapeutics, Inc.	100.00	2
DFTX	Definium Therapeutics, Inc.	100.00	2
JNJ	Johnson & Johnson	100.00	2
D	Dominion Energy, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
SCNX	Scienture Holdings, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2

Dogwood Therapeutics, Inc. Supply Chain